BURLINGAME, CA, UNITED STATES, September 18, 2024 /EINPresswire / -- Latest Report, titled“U.S. Nasal Spray Market” Trends, Share, Size, Growth, Opportunity and ...

Pfizer is considering selling its consumer healthcare business in a deal that could be worth around $15 billion. In a press statement Pfizer said it is “reviewing strategic alternatives ” for ...

Some own their factories, for example GSK, Novartis, Pfizer ... led the Primary Care unit in Egypt from 2007-2009 and successfully integrated the newly acquired Organon Women Health Business.

Editorial Note: Blueprint may earn a commission from affiliate partner links featured here on our site. This commission does not influence our editors' opinions or evaluations. Please view our ...

The Company is in the fast-moving consumer goods (FMCG) business comprising primarily into four business segments such as, home care ... Company and GlaxoSmithKline Consumer Healthcare Limited ...

Using its unparalleled resources and award-winning talent in the areas of Customer Care, Fulfillment and Logistics ... for some of the world's premier brands, including GlaxoSmithKline, Unilever, ...

An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

Former Zantac makers GSK, Pfizer, Sanofi and Boehringer Ingelheim are facing about 4,000 claims in California state court and about 2,000 in various other state courts around the country. The bulk of ...

Former Zantac makers GSK, Pfizer, Sanofi and Boehringer Ingelheim are facing about 4,000 claims in California state court and about 2,000 in various other state courts around the country.